Beryl Drugs Ltd - 524606 - Intimation Regarding Temporary Unavailability Of The Company''s Website Due To An Unexpected Technical IssueBSE · exchange filing · pdf
Source filing Company dossier
Beryl Drugs
BSE:BERLDRG · ISIN INE415H01017
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Beryl Drugs
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Beryl Drugs Ltd - 524606 - Compliance-57 (5) : intimation after the end of quarterBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Change in Registered Office AddressBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Board Meeting Outcome for OUTCOME OF BOARD MEETINGBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Board Meeting Intimation for CHANGE IN REGISTERED OFFICE OF THE COMPANYBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Beryl Drugs Ltd - 524606 - Board Meeting Outcome for OUTCOME OF BOARD MEETINGBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2026BSE · financial results · pdf
Source filing Beryl Drugs Ltd - 524606 - Board Meeting Intimation for Consider And Approve The Audited Financial Statement Including Balance Sheet, As At 31St March, 2026, Statement Of Profit And Loss, Cash Flow And Notes Thereon For The Year Ended 31St March, 2026.BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - PROCEEDINGS OF EGMBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - ANNOUNCEMENT UBDER REGULATION 44 VOTING RESULTS OF EGM HELD ON 11TH MAY 2026BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Announcement Under Regulation 30BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - ANNOUNCEMENT UNDER REGULATION 30BSE · related party · pdf
Source filing Beryl Drugs Ltd - 524606 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - COMPLIANCE CERTIFICATEBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) FOR THE YEAR ENDED 31.03.2026BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Compliance-57 (5) : intimation after the end of quarterBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - FIXES RECORD DATE FOR THE PURPOSE OF EXTRA ORDINARY GENERAL MEETINGBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Board Meeting Outcome for OUTCOME OF BOARD MEETINGBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - EGM ON 11TH MAY, 2026 AT 11:00 A.MBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - INTIMATION OF E-VOTING DATES FOR THE PURPOSE OF EOGM OF THE COMPANYBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - FIXES RECORD DATE FOR THE PURPOSE OF EXTRA ORDINARY GENERAL MEETING OF THE COMPANYBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - DISCLOSURE UNDER REGULATION 29(2) OF SEBI(SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - DISCLOSURE UNDER REGULATION 7(2) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS, 2015BSE · exchange filing · pdf
Source filing Beryl Drugs Ltd - 524606 - DISCLOSURE UNDER REGULATION 29(2) UNDER SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVER) REGULATIONS, 2011BSE · exchange filing · pdf
Source filing